Abstract-We have postulated that the diminished renal capacity to excrete sodium causes nocturnal blood pressure (BP) elevation, which enhances pressure natriuresis in compensation for impaired daytime natriuresis. If such a mechanism holds, high BP during sleep at night may continue until excess sodium is sufficiently excreted into urine. This study examined whether the duration, defined as "dipping time," until nocturnal mean arterial pressure began to fall to Ͻ90% of daytime average became longer as renal function deteriorated. Ambulatory BP measurements and urinary sodium excretion rates were evaluated for daytime and nighttime to estimate their circadian rhythms in 65 subjects with chronic kidney disease. Key Words: chronic kidney disease Ⅲ natriuresis Ⅲ blood pressure Ⅲ circadian rhythm Ⅲ nondipper Ⅲ cardiovascular events I n healthy subjects, blood pressure (BP) normally dips during the night by 10% to 20% from daytime. In some patients with hypertension or chronic kidney disease (CKD), however, BP fails to dip during the night, and these patients have been called "nondippers," whereas those with a normal nocturnal BP dip are called "dippers." We reported previously in patients with essential hypertension that, as BP became sodium sensitive, nocturnal dip in BP was diminished. 1-3 Because glomerular filtration capability is one of the major factors determining sodium sensitivity, 4,5 as a function of loss of glomerular filtration rate, the nocturnal dip in BP may be less pronounced. We recently illustrated this quantitative relationship in CKD 6 and healthy donors after unilateral nephrectomy, 7 where in fact there was an inverse relationship between glomerular filtration rate and the night: day ratio of BP. Therefore, we have postulated that reduced renal capacity to excrete sodium into urine causes nocturnal elevation of BP, ie, nondippers, to compensate for diminished daytime natriuresis by enhancing pressure natriuresis during sleep. 1, 3, 6, 8, 9 If pressure natriuresis during sleep compensates for reduced daytime renal sodium excretion, high BP during sleep at night may continue until excess sodium is sufficiently excreted into urine. In this study, to ascertain the renal mechanisms of nondippers, we examined whether a longer duration is in fact required until a nocturnal BP begins to fall as renal function deteriorates.
I
n healthy subjects, blood pressure (BP) normally dips during the night by 10% to 20% from daytime. In some patients with hypertension or chronic kidney disease (CKD), however, BP fails to dip during the night, and these patients have been called "nondippers," whereas those with a normal nocturnal BP dip are called "dippers. " We reported previously in patients with essential hypertension that, as BP became sodium sensitive, nocturnal dip in BP was diminished. [1] [2] [3] Because glomerular filtration capability is one of the major factors determining sodium sensitivity, 4, 5 as a function of loss of glomerular filtration rate, the nocturnal dip in BP may be less pronounced. We recently illustrated this quantitative relationship in CKD 6 and healthy donors after unilateral nephrectomy, 7 where in fact there was an inverse relationship between glomerular filtration rate and the night: day ratio of BP. Therefore, we have postulated that reduced renal capacity to excrete sodium into urine causes nocturnal elevation of BP, ie, nondippers, to compensate for diminished daytime natriuresis by enhancing pressure natriuresis during sleep. 1, 3, 6, 8, 9 If pressure natriuresis during sleep compensates for reduced daytime renal sodium excretion, high BP during sleep at night may continue until excess sodium is sufficiently excreted into urine. In this study, to ascertain the renal mechanisms of nondippers, we examined whether a longer duration is in fact required until a nocturnal BP begins to fall as renal function deteriorates.
Patients and Methods

Study Population
The subjects were 65 patients (33 men and 32 women; aged 16 to 80 years old; mean age: 47Ϯ18 years; body mass index [BMI]: 22.2Ϯ4.1 kg/m 2 ; body weight: 58.2Ϯ14.2 kg) who were hospitalized with CKD at Nagoya City University Hospital. CKD was defined as the presence of kidney damage or a decreased glomerular filtration rate of Ͻ60 mL/min per 1.73 m 2 for Ն3 months, according to Kidney Disease Outcomes Quality Initiative CKD criteria. 10 Patients with diabetic nephropathy or nephrotic syndrome and those receiving antihypertensive agents or diuretics were excluded from the study. All of the participants were enrolled consecutively after informed consent was obtained. To examine the nighttime BP profile according to the level of renal function, the subjects were classified into tertiles based on their measured creatinine clearance (C cr ; mL/min): first tertile (C cr : 91 to 164 with mean of 122Ϯ21; nϭ22), second tertile (C cr : 50 to 90 with mean of 69Ϯ11; nϭ21), and third tertile (C cr : 5 to 41 with mean of 18Ϯ12; nϭ22).
Study Protocol
The subjects ate a regular salt diet containing Ϸ8 g/d of NaCl for Ն4 weeks and were allowed to pursue usual activities of daily life and water intake, except that they were asked to get up at 6 AM and to go to sleep at 9 PM. Ambulatory BP for 24 hours was monitored every 30 minutes noninvasively with a validated automatic device (model ES-H531, Terumo). The BP values were not considered valid for analysis if data were missing for 2 hours continuously or if the patients awoke during the night and had difficulty falling asleep again. Urinary samples were collected for both daytime (6 AM to 9 PM) and nighttime (9 PM to 6 AM) to estimate the circadian rhythm of the urinary sodium excretion rate (U Na V). These urine collections were combined to measure 24-hour C cr (milliliters per minute). Mean arterial pressure (MAP) was calculated as diastolic BP plus one third of the pulse BP. Daytime BP was calculated as the average of the 30 readings between 6 AM and 9 PM, and nighttime BP was determined as the average of the remaining 18 readings. Night:day ratio of MAP was obtained as the ratio of the averages of all of the readings. When the nighttime MAP reached and remained Ͻ90% of the daytime average continuously for Ն1 hour, this was defined as "nocturnal BP dip." The duration, from the time when subjects went to bed (9:00 PM) until the time when nocturnal BP dip first occurred, was defined as dipping time (DT). From this definition, the longest DT was 8.5 hours, from 9 PM to 5:30 AM. Although MAP reached to Ͻ90% of daytime averages at 6 AM, the subjects were considered to have no nocturnal BP dip. DTs for which the MAP did not reach nocturnal BP dip were all defined as 9 hours, although the subjects had no true DT. DTs as well as night/day ratios of MAP and U Na V were evaluated relative to the 24-hour C cr , which was used as a measure of glomerular filtration rate.
Statistical Analysis
Statistical analyses were performed using SPSS 15.0J (SPSS, Inc). Results are expressed as meansϮSDs throughout the article except in Figure 1 , where SEM was used to avoid the overlap of the lines. The significance of differences across tertiles with different levels of renal function was tested by 1-way ANOVA, followed by a Fisher protected least significant difference test for comparison between the first and third tertiles. The presence of the interaction in MAP and U Na V between day and night change and renal function was studied using 2-way ANOVA. The significance of differences in the sex distribution across tertiles was examined by 2 test. Correlations among variables were evaluated by the least-squares method (r) and Spearman rank correlation () on an appropriate basis.
Because some of the subjects showed no nocturnal BP dip during sleep, regression analysis alone would be insufficient to evaluate the relationship of DT with other variables. Therefore, we adopted time-dependent end point analyses to study the nocturnal BP profile. The first occurrence of nocturnal BP dip was settled as the end point, and the cumulative incidence rate of the first occurrence of the nocturnal dip during 9 hours between 9 PM and 6 AM was compared by Kaplan-Meier analysis across tertiles with different levels of renal function, followed by a log-rank test to estimate the statistical significance. To determine whether renal function was predictive of nocturnal BP dip, hazard ratios and their 95% CIs for nocturnal BP dip were calculated using the Cox proportional hazard regression model. This model incorporated baseline demographic variables, including age, sex, and BMI as well as C cr . P values of Յ0.05 were considered statistically significant in all of the analyses.
Results
The demographics of the 65 subjects with CKD are summarized in Table 1 . The average values of serum creatinine and C cr were 161Ϯ183 mol/L (1.8Ϯ2.1 mg/dL) and 70Ϯ45 mL/min, respectively. According to office BP (average: 126Ϯ21/75Ϯ13 mm Hg), 17 subjects showed their BP as Ն140/90 mm Hg; 4 of 22 in the first tertile, 3 of 21 in the second tertile; and 10 of 22 in the third tertile (Pϭ0.04), with different levels of renal function. Thirty-four subjects had their BP as Ͼ130/80 mm Hg, which was the goal of the antihypertensive therapy for CKD patients: 10 of 22, 9 of 21, and 15 of 22, respectively (Pϭ0.2). According to ambulatory BP monitoring, the numbers of daytime hypertensive subjects (Ͼ135/85 mm Hg) were 6 of 22, 2 of 21, and 11 of 22 (Pϭ0.01), respectively. On the other hand, the numbers of nighttime hypertensive subjects (Ͼ120/75 mm Hg) were 6 of 22, 7 of 21, and 15 of 22 (Pϭ0.01), respectively. Daytime, nighttime, and 24-hour MAP were 91Ϯ13, 88Ϯ15, and 90Ϯ13 mm Hg. The 24-hour averages of MAP were inversely correlated with C cr (rϭϪ0.25; Pϭ0.04). As renal function deteriorated, the nighttime MAP was significantly increased (first tertile: 81Ϯ11; second tertile: 85Ϯ12; third tertile: 97Ϯ16 mm Hg; Pϭ0.0005), whereas the daytime MAP remained unchanged (first tertile: 91Ϯ14; second tertile: 88Ϯ7; third tertile, 94Ϯ17 mm Hg; Pϭ0.3). Day-night changes in MAP were significantly influenced by the level of renal function, because there was a significant interaction (PϽ0.0001) by 2-way ANOVA, indicating that nocturnal decline in MAP was less pronounced as renal function deteriorated. The night/day ratio of MAP was significantly higher in the third tertile than in the first tertile (PϽ0.0001) and was inversely correlated with C cr (rϭϪ0.58; PϽ0.0001). The 24-hour U Na V did not differ across tertiles (Pϭ0.07). As renal function deteriorated, however, the daytime U Na V was reduced (first tertile: 5.4Ϯ1.7; second tertile: 5.1Ϯ1.9; third tertile: 3.1Ϯ1.7 mmol/h; PϽ0.0001), whereas the nighttime U Na V tended to be enhanced (first tertile: 3.3Ϯ1.7; second tertile: 3.9Ϯ1.6; third tertile: 4.5Ϯ2.1 mmol/h; Pϭ0.08). Day-night changes in U Na V were also significantly influenced by the level of renal function, because there was a significant interaction (PϽ0.0001) by 2-way ANOVA, indicating that nocturnal decline in U Na V was less pronounced as renal function deteriorated. The night/day ratio of U Na V was significantly higher in the third tertile than in the first tertile (PϽ0.0001) and was inversely correlated with C cr (rϭϪ0.69; PϽ0.0001). Urinary sodium concentration was significantly lowered during both daytime (Pϭ0.001) and nighttime (Pϭ0.01), as renal function deteriorated from the first to third tertiles.
BP profiles during the night were compared across tertiles with different levels of renal function (Figure 1 ). In the first tertile, BP reached soon after the initiation of sleep to Ͻ90% of daytime averages and hardly exceeded the level again. In the third tertile, on the other hand, BP almost continued elevated throughout the night above the daytime averages and hardly fell to Ͻ90% of the daytime averages. BPs in the second tertile behaved as their intermediates between the first and third tertiles. DT until nocturnal dip of MAP Ͻ90% of the daytime average differed across tertiles (PϽ0.0001) and was significantly longer in the third tertile than in the first tertile (PϽ0.0001), as shown in Table 1 . DT was inversely correlated with C cr in nonparametric regression (ϭϪ0.61; PϽ0.0001) and showed positive relationships with the night: day ratios of MAP (ϭ0.84; PϽ0.0001) and U Na V (ϭ0.61; PϽ0.0001; Figure 2 ). Even if 24 patients who did not reach nocturnal BP dip were excluded, the similar relationships were obtained in the remaining 41 subjects (DT and C cr : ϭϪ0.35, Pϭ0.03; DT and night/day ratio of MAP: ϭ0.50, Pϭ0.002; DT and night/day ratio of U Na V: ϭ0.38, Pϭ0.02; nϭ41). In addition, the night/day ratio of MAP was positively correlated with the night/day ratio of U Na V (rϭ0.57; PϽ0.0001; nϭ65). During the 9 hours between 9 PM and 6 AM, 41 of the 65 subjects attained a nocturnal BP dip. In 23 of these 41 patients, nocturnal MAP never exceeded 90% of the daytime average once it had fallen. On the other hand, in the remaining 18 patients, MAP exceeded the 90% of the daytime average again very slightly.
In 24 individuals who showed no nocturnal dip, most of the 18 BP readings during the night exceeded daytime averages. In 19 of 24 subjects, nighttime BP never reached Ͻ90% of daytime averages, whereas in 5 of 24 subjects, nighttime BP fell to Ͻ90% of daytime averages for only Ͻ1 hour. Because DT was defined as 9 hours in all 24 of the subjects who showed no nocturnal dip, regression analysis alone would be insufficient to evaluate the relationships between DT and other variables. Therefore, we compared the cumulative incidence rate of the nocturnal BP dip across tertiles with different levels of renal function using Kaplan-Meier analyses (Figure 3) , being significantly different (PϽ0.0001 by log-rank test) and higher in the first tertile than in the third tertile. These findings indicate that, as renal function deteriorated from the first to the third tertiles, the probability of nocturnal BP dip was reduced. Cox proportional regression model, including baseline variables such as age, sex, and BMI as well as C cr , identified independent factors for nocturnal BP dip (Table 2 ). This model indicated that only C cr was a significant determinant of nocturnal BP dip (hazard ratio: 1.017; 95% CI: 1.008 to 1.026; Pϭ0.0002), with a higher C cr being associated with a higher incidence of nocturnal BP dip. Age, sex, and BMI did not influence the nocturnal BP dip. Hazard ratios of nocturnal BP dip adjusted for age, sex, and BMI were 0.37 (95% CI: 0.17 to 0.79; Pϭ0.01) in the second tertile and 0.20 (95% CI: 0.08 to 0.55; Pϭ0.002) in the third tertile compared with the first tertile. Results on DT were essentially same for both systolic and diastolic BPs as for MAP in our study subjects.
Discussion
Our study showed that, as renal function deteriorated in patients with CKD, nocturnal BP remained elevated for a longer duration during sleep until BP began to fall. This duration, DT, was positively correlated with the night/day ratios of BP and urinary sodium excretion and was negatively correlated with C cr , supporting our hypothesis that BP must remain elevated during the night until excess sodium is sufficiently excreted by pressure natriuresis in patients with sodium-sensitive hypertension, including CKD. 9 These findings pointed out for the first time that the prolonged duration until nocturnal BP dip is one of the essential components of the nondipper pattern of the circadian BP rhythm.
Nocturnal dip in BP during sleep was observed in 41 of 65 patients, and in 23 of these 41 patients MAP continued to Ͻ90% of the daytime average once the dip was achieved. In the remaining 18 of 41 patients, MAP rose again and exceeded slightly the 90% of the daytime average after the first dip. However, this BP re-elevation lasted only for no more than 1 hour, and then the nighttime MAP remained lowered thereafter. Thus, at least in CKD patients, BP generally does not rise again once BP falls during sleep, indicating that DT can be estimated fairly precisely. The highly significant relationship between DT and the night/day ratio of MAP suggests that nondipping phenomenon, defined as a night/day ratio of MAP Ն0.9, is almost exclusively explained by the prolongation of the duration until MAP falls to Ͻ90% of the daytime average. These findings all indicate that DT seems meaningful and becomes longer as renal function deteriorates.
We found that 24 of the 65 subjects showed no nocturnal BP dip entirely between 9 PM and 6 AM and their DTs were not obtained, although we defined 9 hours in their regression analyses. These results made it difficult to analyze the relationships between DT and other parameters. Therefore, nocturnal dip of MAP to Ͻ90% of its daytime average was Figure 2 . Relationships of the DT (hour) with C cr (mL/min) as a marker of renal function and night/day ratios of MAP (mm Hg) and U Na V (mmol/h) in patients with CKD (nϭ65). The DT was defined as the duration until nocturnal MAP began to fall to Ͻ90% of the daytime average. It was increased as renal function deteriorated and was directly correlated with the night/day ratios of both MAP and U Na V in the whole of the subjects (nϭ65; E and F). Even if 24 patients (E) who did not reach nocturnal BP dip were excluded, the similar relationships were obtained in the remaining 41 subjects (F; DT and C cr : ϭϪ0.35, Pϭ0.03; DT and night/day ratio of MAP: ϭ0.50, Pϭ0.002; DT and night/day ratio of U Na V: ϭ0.38, Pϭ0.02). Nocturnal BP dip and renal function. Kaplan-Meier curves for the cumulative incidence rate of BP dip during the night (9 hours) were compared across tertiles with different levels of renal function. Subjects were divided into tertiles according to C cr (mL/min): first tertile (C cr : 91 to 164; nϭ22); second tertile (C cr : 50 to 90; nϭ21); third tertile (C cr : 5 to 41; nϭ22). The probability of a nocturnal BP dip differed significantly across tertiles (log-rank test, PϽ0.0001) and was significantly reduced from first to third tertiles. settled as the end point, and the cumulative incidence rate of the first occurrence of the nocturnal dip was compared by Kaplan-Meier analysis across tertiles with different levels of renal function. As renal function deteriorated, the cumulative incidence rate was significantly reduced. In addition, Cox proportional regression analysis identified renal function as the sole determinant of a nocturnal BP dip. Age differed across tertiles but was not a significant determinant, and even after adjustments for age, sex, or BMI, renal function was found to be an independent risk factor for nocturnal BP dip. We believe that these results show that nocturnal BP dip is manipulated mainly by renal dysfunction. These timedependent end point analyses clearly showed, irrespective of the data distribution, that a longer duration was required until nocturnal BP dip as renal function deteriorated. It would be useful to examine whether a higher rate of urinary sodium excretion continues for a longer time during sleep until a simultaneous dip in BP during sleep, as we discussed above. It is very difficult to test this relationship in humans, however, because the insertion of a bladder catheter would be necessary to measure the urinary sodium excretion rate precisely every hour during sleep. Recently, the circadian acrophase of BP rhythm was reported to be delayed with a blunted amplitude as renal function deteriorated in 214 children with mild-to-moderate renal dysfunction. 11 In addition, association between the nondipper pattern of circadian rhythm of BP and impaired renal capacity to excrete sodium into urine was confirmed based on a large number of subjects (nϭ325). 12 These 2 reports are consistent with our hypothesis mentioned. Bankir et al 12 showed that the low rate of sodium excretion during daytime was because of a lower daytime sodium concentration in the urine and that daytime sodium concentration was negatively and strongly associated with nighttime BP. However, in our study, daytime sodium concentration was not correlated with nighttime MAP (rϭϪ0.21; Pϭ0.1) or night/day ratio of MAP (rϭϪ0.21; Pϭ0.09). Both daytime and nighttime urinary sodium concentrations were lowered in parallel as renal function deteriorated from the first to the third tertiles, being independent of regulation of circadian rhythms. This is contrast to U Na V, because daytime U Na V was significantly reduced from the first to the third tertiles, whereas nighttime U Na V tended to be increased. In addition, daytime U Na V was not correlated with daytime MAP (rϭϪ0.14; Pϭ0.3), whereas nighttime U Na V tended to be positively associated with nighttime MAP (rϭ0.22; Pϭ0.08). These findings suggest that U Na V is a key to determine circadian BP rhythm in both our study and that of Bankir. 12 A tight pressure-natriuresis relationship during the night, but not during the day, has been reported, 13 also supporting our hypothesis and the importance of U Na V. Relative contributions of U Na V and urinary sodium concentration in this relationship may be different among study populations with different levels of renal function.
A nondipper pattern of circadian BP rhythm 14 -19 and sodium sensitivity of BP 20 -22 are considered to be risk factors for cardiovascular disease (CVD), and both tend to be enhanced as renal function deteriorates. It is also well known that BP during sleep has a greater impact on CVD than the daytime BP or the 24-hour BP. [23] [24] [25] Recently, it has been recognized that even mild renal dysfunction is a strong predictor for future CVD, 26 -28 and the risks of CVD are enhanced as renal function deteriorates. 27, 28 However, the precise mechanisms through which renal dysfunction causes CVD remain unknown. We, therefore, propose that nondipping of BP may be an important mechanism causing CVD in patients with CKD as a function of renal impairments. DT may not only be a more quantitative index for the circadian BP rhythm but may also be a novel marker for an accurate prediction of future CVD.
There are several limitations in this study. First, the lack of a control group of people without CKD does not allow for comparison of the results presented here. Second, the present study is cross-sectional but not longitudinal. Because we measured data only at the single point, potential day-to-day variability could not be considered. Because patients were studied under hospitalization, in addition, different data on circadian BP rhythm might be obtained in free-living people. Finally, our subjects were limited to particular patients whose BP remained almost normal on a regular salt diet without antihypertensive agents or diuretics, which could have potently influenced the circadian rhythms of BP and natriuresis. 29, 30 It should, therefore, be noted that our study could not establish a clear cause-effect relationship.
In conclusion, our results demonstrate that patients with greater renal dysfunction in CKD require a longer duration until BP falls during the night. The prolonged duration until BP dip during sleep seems an essential component of the nondipper pattern of the circadian BP rhythm and may be a more quantitative index of the nondipper pattern of circadian BP rhythm.
Perspectives
As renal function deteriorates, nocturnal dip in BP is diminished, and longer duration is required until BP dips during the night. DT, introduced for the first time in this study, may express the nondipper phenomenon quantitatively in a different viewpoint from the night/day ratio of BP. Although both of them are highly correlated to each other, we think that DT reflects more physiological meaning and a comprehensive state, including renal function and sodium retention, than just their night/day ratio. Because it is well known that BP during sleep has a greater impact on CVD than BP during daytime, circadian BP rhythm itself must be considered as one of the important risk factors for CVD. DT may be used as a novel marker to quantitatively analyze circadian BP rhythm. Furthermore, shortening DT may become a new target of antihypertensive therapy in future.
